An SBLC can carry an impressive face value and still be unsuitable for the proposed transaction.
The useful first question is whether the actual instrument can be accepted for the intended purpose. That requires more than a summary of the issuing bank and amount.
Our overview describes an SBLC Trade Programme for qualifying instruments from an indicative US$100 million face value. The instrument is used as approved credit enhancement under that particular route.
Establish what the instrument permits
The review considers authenticity, ownership, authority, issuing bank, wording and the proposed delivery route. Each affects whether the receiving party can accept the instrument for the contemplated structure.
An SBLC prepared for a different purpose may require a different assessment. The fact that a document exists does not establish that its terms fit the programme.
The client should be able to explain who owns the instrument, who has authority to instruct and how it will be verified through the approved process.
Keep face value and approved participation distinct
The overview describes programme economics being applied to an approved lending-value allocation rather than automatically to the full face value. The accepted basis and deductions must be confirmed in writing.
This is relevant where an instrument owner is discussing project funding. A project budget cannot be calculated simply by treating the headline face value as cash available to spend.
Understand the particular route
The named SBLC route is described as credit enhancement, with the instrument itself not sold or monetised under the standard structure. Wider instrument opportunities are assessed separately and may have different treatment.
The definitive documents need to establish the instrument's permitted use, validity requirements, term and release conditions. The client must understand the obligation to keep it available for the agreed period.
If realised output is intended for a project or treasury, its allocation and receiving instructions are documented alongside the programme agreement.
If you have a genuine instrument for review, send a non-confidential summary of the issuing bank, face value, owner, jurisdiction and intended use. We can then identify the evidence required to determine whether the file fits a current route.
Instrument acceptance, valuation basis, treatment and availability are transaction-specific. An indicative programme description does not confirm approval or output.